medigraphic.com
ISSN 1029-3019 (Electronic)

2014, Number 05

<< Back Next >>

MediSan 2014; 18 (05)

Guillain-Barré syndrome in the childhood

González VD, Aguilera POR, Ruiz MFJ, Casamajor CMA, Parrón CI

Language: Spanish
References: 20
Page: 613-620
PDF size: 109.99 Kb.


ABSTRACT

A descriptive and prospective study of 25 patients with Guillain-Barré syndrome, assisted in the Teaching Southern Children Hospital in Santiago de Cuba was carried out from January, 2006 to December, 2012, with the aim of identifying their clinical and epidemiological characteristics and to determine the usefulness of the treatment applied. Children younger than 5 years (40.0%), male sex and previous upper respiratory infection (both with 60.0%), as well as the muscular weakness and osteotendinous areflexia (76.0% in each case) prevailed. The inflammatory and acute desmyelinating polyrradiculoneuropathy was the most frequent clinical variant (72.0%). Either the treatment with intravenous human immunoglobulin as rehabilitation were beneficial and the mortality was low (4.0%).


REFERENCES

  1. Ibáñez Micó S, Pons Aliaga C, Polo Martín P, Aleu Pérez-Gramunt M. Dolor lumbar y de miembros inferiores con rechazo de la deambulación como modo de presentación de síndrome de Guillain-Barré. An Pediatr (Barc). 2007;66(1):87-106.

  2. Yuki N, Hartung HP. Guillain-Barré syndrome. N Engl J Med 2012;367(17):1673.

  3. Erazo Torricelli R. Síndrome de Guillain Barré en pediatría. Medicina (B. Aires). 2009 [citado 26 Ago 2010]; 69(1 Supl 1). Disponible en: http://www.scielo. org.ar/scielo.php?script=sci_arttext&pid=S0025-76802009000200010

  4. Incecik F, Ozlem Hergüner M, Altunbasak S, Yıldızdas D. Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barré syndrome. J Pediatr Neurosci. 2011;6(2):138–40.

  5. Walling AD, Dickson G. Guillain-Barré syndrome. Am Fam Physician. 2013; 87(3):191-7.

  6. Menkes JH, Sarnat HB, Moria BL. Child Neurology. 7 ed. Philadelphia: Lippincott Williams and Wilkins; 2006. p. 600-610.

  7. Pérez Lledó E, Díaz Vico A, Gómez Gosálvez FA. Guillain-Barré syndrome: clinical presentation and prognosis in children under six years-old. An Pediatr (Barc). 2012;76(2):69-76.

  8. Smith SA, Ouvrier R. Peripheral Neuropathies in Children. En: Swaiman KF, Ashwal S. Pediatric Neurology. Principles and Practice. 3 th. St Louis: Mosby Inc;1999. p. 1178-1201.

  9. McMillan HJ, Darras BT, Kang PB. Autoimmune neuromuscular disorders in Childhood. Curr Treat Options Neurol. 2011;13(6):590–607.

  10. Akbayram S, Doğan M, Akgün C, Peker E, Sayιn R, Aktar F, et al. Clinical features and prognosis with Guillain-Barré syndrome. Ann Indian Acad Neurol. 2011;14(2): 98–102.

  11. Bloch SA, Akhavan M, Avarello J. Weakness and the inability to ambulate in a 14- Month-Old Female: a case report and concise review of Guillain-Barré syndrome. Case Rep Emerg Med. 2013;2013:1-5.

  12. Vigil Zulueta IA, Guerra Santana A, Ochoa Undangarain L, Hernández Zayas MS, Domínguez Osorio CA. Rehabilitación de niños y adolescentes con síndrome de Guillain-Barré. MEDISAN. 2012[citado 3 jun 2013];16(10).

  13. Kannan MA, Ch RK, Jabeen SA, Mridula KR, Rao P, Borgohain R. Clinical, electrophysiological subtypes and antiganglioside antibodies in childhood Guillain- Barré syndrome. Neurol India. 2011;59(5):727-32.

  14. López Esteban P, Gallego I, Gil Ferrer V. Electrodiagnostic criteria for childhood Guillain-Barre syndrome. Eight years' experience. Rev Neurol. 2013;56(5):275-82.

  15. Ropper AH, Samuels MA. Adams and Victor’s Principles of Neurology. 9 ed. New York: McGraw-Hill;2009. p. 1261-69.

  16. Islam Z, Jacobs BC, Islam MB, Mohammad QD, Diorditsa S, Endtz HP. High incidence of Guillain-Barré syndrome in children, Bangladesh. Emerg Infect Dis. 2011;17(7):1317–18.

  17. Islam Z, Gilbert M, Mohammad QD, Klaij K, Li J, van Rijs W, et al. Guillain-Barré Syndrome-Related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS One. 2012;7(8):e43976.

  18. Baker MG, Kvalsvig A, Zhang J, Lake R, Sears A, Wilson N. Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010. Emerg Infect Dis. 2012;18(2):226–33.

  19. Hu MH, Chen CM, Lin KL, Wang HS, Hsia SH, Chou ML, et al. Risk factors of respiratory failure in children with Guillain-Barré syndrome. Pediatr Neonatol. 2012;53(5):295-9.

  20. Vázquez López ME, Almuiña Simón C, Calviño Costas MC, Yáñez Mesía S, González Gómez FJ, Fernández Iglesias JL. Guillain-Barré syndrome: an unusual saltatorytype variant in the paediatric age. Rev Neurol. 2012;55(5):317-8.




2020     |     www.medigraphic.com